Head to head
OptimasMAX vs Venus Versa (2026)
The biggest practical difference is cost of entry: Venus Versa's new pricing is $70k–$110k, while OptimasMAX's is $125.9k–$275k. They are used for different treatments (Venus Versa: body contouring; OptimasMAX: IPL/RF platform), so the right pick depends on which treatments you're building demand for.
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
Price comparison
New price range
- Venus Versa
- $70k–$110k
- InMode OptimasMAX
- $125.9k–$275k
Used asking range
- Venus Versa
- $20k–$45k
- InMode OptimasMAX
- $40.0k–$75.0k
Payback calculator
- Venus Versa
- View ROI calculator
- InMode OptimasMAX
- View ROI calculator
Next step
Consumable economics
Consumable cost / lock-in
- Venus Versa
- No per-treatment disposable. Applicators are pulse-limited wear items: IPL applicators warranted for 12 months or 150,000 pulses, and the NanoFractional RF tip up to 700 pulses (Venus). Refurbishment is $1,500 per applicator including a chip shot-count reset (Laser Part Repair USA); refurbished applicators sell for $2,200-$2,499 (Parts4Laser). The internal shot-count chip is therefore a soft lock that third-party refurbishers can reset.
- InMode OptimasMAX
- —
Service cost
- Venus Versa
- Not published
- InMode OptimasMAX
- Not published
FDA clearance
FDA status & indication
- Venus Versa
- FDA ClearedK153717“The Venus Versa System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”
- InMode OptimasMAX
- FDA ClearedK251632“The Optimas MAX System with the Diolaze XL MAX is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The Fusion Light and the Fusion Dark are intended for hair removal. The Optimas MAX System with the VasculazeMAX is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The Optimas MAX System with the Lumecca Peak Applicators are indicated for use for the following treatments: * The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); * The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, superficial leg veins and venous malformations. The Optimas MAX System with the Plus and Forma Handpieces are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation The Optimas MAX System with the he Morpheus8 Applicators is intended for use in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 Applicator is limited to Skin Types I-IV.”
Which chains run each
Chain adoption
- Venus Versa
- 1 recorded pairing
- InMode OptimasMAX
- 0 recorded pairings
Chains using it
- Venus Versa
- Formula Wellness(Confirmed)
- InMode OptimasMAX
- —
Approved reviews
- Venus Versa
- 0
- InMode OptimasMAX
- 0
Specs and platform
Manufacturer
- Venus Versa
- Venus Concept
- InMode OptimasMAX
- InMode
Built by (OEM)
- Venus Versa
- Venus Concept Inc.
- InMode OptimasMAX
- InMode Ltd.
Category
- Venus Versa
- Body Contouring
- InMode OptimasMAX
- IPL/RF platform
Technology
- Venus Versa
- Multi-application platform w/ body RF (IPL)
- InMode OptimasMAX
- Multi-application IPL and RF platform (IPL)
Launch year
- Venus Versa
- 2016
- InMode OptimasMAX
- —
Status
- Venus Versa
- Current
- InMode OptimasMAX
- Current
OEM platform
- Venus Versa
- —
- InMode OptimasMAX
- —
Alternatives
Other devices in the same subcategory.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Prices are researched estimates, not quotes. Not medical, legal or regulatory advice.